We focused only on the combinations involving the PDE10A inhibitor PF-2545920 [21] because there is evidence of the high accumulation of this drug in the brain [22], and it was shown to be effective in colorectal cancer [23,24]. The gene discussed is PDE10A; the disease is colorectal cancer.